ESC Congress 2011

27 - 31 August 2011, Paris - France

Session Details

Poster session 2: Heart Failure - Left ventricular dysfunction
Sun 28 Aug 14:00 - 18:00 Prognosis Poster Session Posters - Poster Zone C

Abstract Slides/e-posters Video Report

List of Presentations

Related documents
14:00P1734Severe low-cardiac output heart failure patients bridged to beta-blockade by enoximone: prolonged survival without heart transplantationAna Alina CONSTANTINESCU (Rotterdam, NL)
14:00P1735Predictors of outcome in patients with chronic heart failure over a 5 year follow-up periodJavaid IQBAL (Sheffield, GB)
14:00P1736Post traumatic stress disorder is associated with increased mortality in stable outpatients with elevated B-type natriuretic peptideAlan MAISEL (Solana Beach, US)
14:00P1737The prognostic value of a new tissue Doppler parameter in patients with heart failureCristian MORNOS (Timisoara, RO)
14:00P1738Outcome of patients with right ventricular systolic dysfunction and left ventricular systolic dysfunction and/or heart failure. A meta-analysisIgnacio IGLESIAS GARRIZ (Leon, ES)
14:00P1739Right ventricular dysfunction predicts clinical outcomes for patients following the implantation of cardiac resynchronisation therapyKaushik GUHA (London, GB)
14:00P1740Soluble ST2 predicts outcome in heart failure of ischemic aetiologyKaspar BROCH (Oslo, NO)
14:00P1741A novel risk model for patients admitted for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: EFFECT-HF scoreKhibar SALAH (Zaandam, NL)
14:00P1742Serum albumin level reflects nutritional and inflammatory status in patients with acute decompensated heart failureYoshiharu KINUGASA (Yonago, JP)
14:00P1743Exercise-induced reduction of lymphocyte G-protein coupled receptor kinase-2 (GRK2) strongly predicts improved survival in patients with heart failureGiuseppe RENGO (Telese Terme, IT)
14:00P1744Risk factors for fatal and non-fatal cardiovascular events in 9306 subjects in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) TrialJohn MCMURRAY (Glasgow, GB)
14:00P1745Sitagliptin reduces myocardial fibrosis and hypertrophy and enhances PPARd activation in experimental Type-2 Diabetes.Oscar LORENZO GONZALEZ (Madrid, ES)
14:00P1746The polymorphism G5665T on endothelin-1 gene affects endothelin-1 levels in patients with heart failureDimitris TOUSOULIS (Athens, GR)
14:00P1747Improvement in left ventricular ejection fraction during clinical followup in the canadian heart failure networkMalcolm ARNOLD (London, CA)
14:00P1748Left sympathetic surgical blockade in systolic heart failure patients with optimised medical therapy Germano Emilio SOUZA (Sao Paulo, BR)
14:00P1749Disparity between matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 correlated with the severity and adverse prognosis in patients with heart failure and systolic dysfunctTetsuji MORISHITA (Fukui, JP)
14:00P1750HCN channel inhibition with ivabradine prevents sudden arrhythmic death in a mouse model of dilated cardiomyopathy.Yoshihiro KUWABARA (Kyoto, JP)
14:00P1751Transthoracic echocardiography with Doppler tissue imaging for predict weaning failure from mechanical ventilation Sebastien MOSCHIETTO (Nice, FR)
14:00P1752A mechanism of sudden cardiac death in patients with congestive heart failure and cheyne-stokes resiprationThomas BITTER (Bad Oeynhausen, DE)
14:00P1753Impact of high risk pregnancy on left ventricular function during peripartum period: from the toyota peripartum cardiomyopathy studyHisashi UMEDA (Toyota, JP)
14:00P1754Evidence of subtle left ventricular systolic dysfunction and worse prognosis in asymptomatic hemodialysis patients with preserved left ventricular ejection fraction and elevated cardiac troponin TYen-Wen LIU (Tainan, TW)
14:00P1755High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunctionAggeliki GOUZIOUTA (Ekali, GR)
14:00P1756Anaemia versus iron deficiency in heart failureDominik BERLINER (Hannover, DE)
14:00P1757(W)Prevalence and misdiagnosis of heart failure in care homes: HFinCH diagnostic studyTo Be Announced
14:00P1758Accurate design of randomized placebo-controlled clinical trials for assessment of stem cell effects on cardiac regenerationElena GOLUKHOVA (Moscow, RU)
14:00P1759Does malnutrition determined by the Mini Nutritional Assessment (MNA) test retain its influence on long-term mortality in hospitalized patients with heart failure?Juan Luis BONILLA PALOMAS (Cordoba, ES)
14:00P1760Single centre long term follow-up of undersized mitral annuloplasty for mitral regurgitation in end-stage dilated cardiomyopathyGiuseppe BRUSCHI (Milan, IT)
14:00P1761Anemia in heart failure: iron metabolism dictates hepcidin levels in stable outpatientsNadine CLAUSELL (Porto Alegre, BR)
14:00P1762Treatment at discharge of acute heart failure: The OFICA studyDamien LOGEART (Paris, FR)
14:00P1763Percutaneous carbon dioxide gas mist ameliorates cardiac remodeling after myocardial infarction in ratsTakanori YAMAZAKI (Osaka, JP)
14:00P1764Results of a randomized clinical study evaluating nurse-driven telemedicine interventions for high risk chronic heart failure patients with frequent rehospitalizations Hans PERSSON (Stockholm, SE)
14:00P1765Incidence and predictors of postoperative Heart Failure(HF) in patients undergoing elective noncardiac surgery Anitha RAJAMANICKAM (Wilmington, US)
14:00P1766Incidence of cardiotoxicity of Trastuzumab in Her2Neu positive breast cancer patients: a retrospective cohort studyCrista LIESTING (Hendrik Ido Ambacht, NL)
14:00P1767Gender-dependent characteristics of sleep-disordered breathing in patients with chronic heart failureHolger WOEHRLE (Ulm, DE)
14:00P1768Doxorubicin causes downregulation of GRP78 leading to ER-stress induced cell-death and cardiac dysfunctionHenrike TSCHESCHNER (Heidelberg, DE)
14:00P1769AAV6 mediated cardiac betaARKct gene therapy rescues failing myocardium and normalizes neurohumoral signalling in a pig model of ischemic cardiomyopathyPhilipp SCHLEGEL (Heidelberg, DE)
14:00P1770Neural cell adhesion molecule is a cardioprotective factor upregulated by metabolic stress Kazuya NAGAO (Osaka, JP)
14:00P1771Prognostic implications of serum heat shock protein 60 levels in patients with acute heart failure.Clara BONANAD LOZANO (Valencia, ES)
14:00P1772Prognostic impact of sleep disordered breathing and their treatment in chronic heart failureThibaud DAMY (Creteil, FR)
14:00P1773Palliative care in chronic heart failureMartin A DENVIR (Edinburgh, GB)
14:00P1774Acute effects of the targeted anti-cancer agent sunitinib on cardiac contractilityDirk VON LEWINSKI (Graz, AT)
14:00P1775Estrogen therapy reverses chronic heart failure and restores local heart estrogen and aromatase CYP450 levels in miceMansoureh EGHBALI (Los Angeles, US)
14:00P1776Persistence of viral activity associated with inflammation in endomyocardial biopsy specimens of patients with left ventricular dysfunction predicts better unfavourable outcomes Aggeliki GOUZIOUTA (Ekali, GR)
14:00P1777Age, but not gender, influences quality of care in heart failure - results from a contemporary U.K. cohort.Paul Michael HAYDOCK (London, GB)
14:00P1778Coronary venous retention - a novel feature in heart failure evidenced by mean of cardiac computed tomographyAgnieszka MLYNARSKA (Myslowice, PL)
14:00P1779Impact of cardiac contractility modulation on left ventricular global function measured by two-dimensional speckle tracking imagingQing ZHANG (Sichuan, CN)
14:00P1780Nexilin deficient neonatal mice display dilated cardiomyopathy and systolic dysfunctionTo Be Announced
14:00P1781Chronic heart failure patients are vitamin D deficient and hyperparathyroid, levels of each relate to markers of severityKlaus WITTE (Leeds, GB)
14:00P1782Galectin 3 predicts mortality and response to statin therapy in chronic heart failureLars GULLESTAD (Oslo, NO)
14:00P1783The anticancer mTOR-inhibitor temsirolimus induces cardiac dysfunction in miceNicola MAUREA (Naples, IT)
14:00P1784The significance of optimal medical therapy before implantation of ICD and CRT-P/CRT-D in the avoidance of non-evidence-based use of the devicesMiklos DEKANY (Budapest, HU)
14:00P1785Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic deathMeihua LI (Osaka, JP)
14:00P1786Long-term effects of implantable hemodynamic monitoring in patients with moderate heart failureTo Be Announced
14:00P1787Stratifying prognosis in heart failure: nutritional status versus body mass index.Paloma GASTELURRUTIA (Badalona, ES)
14:00P1788Recent in-hospital mortality trends among patients with heart failure in the netherlandsJetty OVERBEEK (Utrecht, NL)
14:00P1789Left ventricular diastolic dysfunction and preceding courses of cardiovascular risk factors: a 17-year follow-up studyKatja VAN DEN HURK (Amsterdam, NL)